CVS Health elects Boston Scientific CEO Michael F. Mahoney to board

CVS HEALTH Corp

Michael F. Mahoney elected to CVS Health Board, effective November 1, 2023.
Mahoney has been President and CEO of Boston Scientific (BSX) since 2012.
Board determined Mahoney independent under NYSE and CVS guidelines.
Compensation consistent with other non-employee directors, subject to proration.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael F. Mahoney

Director

CVS · CVS HEALTH Corp

Effective: 2023-11-01
Filed: September 21, 2023, 7:59 PM ET

On September 20, 2023, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected Michael F. Mahoney to serve on the Board, effective November 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael F. Mahoney was elected as Director at CVS HEALTH Corp.

Action: elected
Role: Director

Exact text from the filing

On September 20, 2023, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected Michael F. Mahoney to serve on the Board, effective November 1, 2023.

View on SEC.gov

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0000947871-23-000948

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.